Back to Search
MICHAEL SPIOTTO, M.D., PH.D.
M.D., PH.D.
Radiation Oncology Physician
NPI: 1386831030IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
036.125468(IL)A96538(CA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2005
Research & Publications (17)
Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.
PMID 16674971·J Immunol Methods·2006
7-preclinical
Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells.
PMID 15934727·Cancer Immun·2005
7-preclinical
Bystander elimination of antigen loss variants in established tumors.
PMID 14981514·Nat Med·2004
7-preclinical
Genetic changes occurring in established tumors rapidly stimulate new antibody responses.
PMID 12702750·Proc Natl Acad Sci U S A·2003
7-preclinical
Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation.
PMID 14630209·Curr Opin Immunol·2003
6-review
Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
PMID 12479820·Immunity·2002
7-preclinical
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
PMID 10639189·Prostate·2000
8-other
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP.
PMID 10617865·Prostate·2000
8-other
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy.
PMID 18707829·Int J Radiat Oncol Biol Phys·2009
8-other
Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.
PMID 19010906·Cancer Res·2008
8-other
Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.
PMID 18207668·Int J Radiat Oncol Biol Phys·2008
8-other
Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy.
PMID 17935902·Int J Radiat Oncol Biol Phys·2008
8-other
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients.
PMID 17459606·Int J Radiat Oncol Biol Phys·2007
4-observational
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
PMID 17210731·J Exp Med·2007
7-preclinical
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.
PMID 14871849·Cancer Res·2004
7-preclinical
Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
PMID 12695490·J Exp Med·2003
7-preclinical
Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines.
PMID 10579793·Prostate·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5758 S MARYLAND AVE, DEPARTMENT OF RAD ONC, THE UNIVERSITY OF CHICAGO
CHICAGO, IL 60637 - Phone
- (773) 702-6860
Quick Facts
- NPI
- 1386831030
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 17
Are you this provider?
Claim Your Profile